KDM4D
| Official symbol: | KDM4D |
| Full name: | lysine demethylase 4D |
| Location: | 11q21 |
| Also known as: | FLJ10251, JMJD2D |
| Entrez ID: | 55693 |
| Ensembl ID: | ENSG00000186280 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.16 |
|
|
|
| Recurrently deleted in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | NA |
|
|
|
| |
|
|
|
| Functional class: | Epigenetic |
| JensenLab PubMed score: | 28.33 (Percentile rank: 53.07%) |
| PubTator score: | 11.83 (Percentile rank: 42.90%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
